{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:35:48Z","timestamp":1790375748260,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bbmt.2015.08.036","type":"journal-article","created":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T12:05:49Z","timestamp":1441454749000},"page":"441-448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Nonmyeloablative Stem Cell Transplantation with Alemtuzumab\/Low-Dose Irradiation to Cure and Improve the\u00a0Quality of Life of Adults with Sickle Cell Disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Santosh L.","family":"Saraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie L.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash","family":"Jalundhwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Campbell-Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Gowhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johara","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Peace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Molokie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis L.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Levinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Simon","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe G.N.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor R.","family":"Gordeuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Rondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.08.036_bib1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.08.036_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.21408","article-title":"The cost of health care for children and adults with sickle cell disease","volume":"84","author":"Kauf","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2015.08.036_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pbc.24776","article-title":"PedsQL Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity","volume":"61","author":"Panepinto","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2015.08.036_bib4","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.036_bib5","first-page":"18","article-title":"Bone marrow transplantation for sickle cell disease. The European experience","volume":"16","author":"Vermylen","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2015.08.036_bib6","first-page":"1918","article-title":"Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease","volume":"95","author":"Walters","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.036_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2007.06592.x","article-title":"Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research","volume":"137","author":"Panepinto","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2015.08.036_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1702518","article-title":"Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease","volume":"26","author":"van Besien","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.036_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","article-title":"Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia","volume":"9","author":"Iannone","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.036_bib10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.bbmt.2008.08.016","article-title":"Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease","volume":"14","author":"Krishnamurti","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.036_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2015.08.036_bib12","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bolanos-Meade","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.036_bib13","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.036_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.bbmt.2015.08.036_bib15","series-title":"SF-36 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"2000"},{"key":"10.1016\/j.bbmt.2015.08.036_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J\u00a0Health Econ"},{"key":"10.1016\/j.bbmt.2015.08.036_bib17","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.5334\/ijic.65","article-title":"Statistical significant change versus relevant\u00a0or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research","volume":"2","author":"Middel","year":"2002","journal-title":"Int J Integr Care"},{"key":"10.1016\/j.bbmt.2015.08.036_bib18","series-title":"Statistical power analysis for the behavioral sciences (ed Second)","author":"Cohen","year":"1988"},{"key":"10.1016\/j.bbmt.2015.08.036_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-7525-1-4","article-title":"What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D","volume":"1","author":"Walters","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.bbmt.2015.08.036_bib20","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","article-title":"Allogeneic hematopoietic stem-cell transplantation for sickle cell disease","volume":"361","author":"Hsieh","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.08.036_bib21","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1182\/blood-2011-07-367490","article-title":"Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?","volume":"118","author":"Kuentz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.036_bib22","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood.V97.12.3960","article-title":"Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia","volume":"97","author":"Iannone","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.036_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/bbmt.2001.v7.pm11787529","article-title":"Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia","volume":"7","author":"Walters","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.036_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbmt.2014.11.680","article-title":"Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease","volume":"21","author":"Villa","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.036_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/pbc.24036","article-title":"Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT)","volume":"59","author":"Kelly","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2015.08.036_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbmt.2014.12.007","article-title":"Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease","volume":"21","author":"Bhatia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.036_bib27","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.bbmt.2015.01.010","article-title":"Allogeneic hematopoietic cell transplantation for children with sickle cell disease is beneficial and cost-effective: a single-center analysis","volume":"21","author":"Arnold","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.036_bib28","unstructured":"World Health Organization. Global distribution of haemoglobin disorders, in terms of births of affected infants per 1000 births. Available at: http:\/\/www.who.int\/genomics\/public\/Maphaemoglobin.pdf. Accessed April 1, 2015."},{"key":"10.1016\/j.bbmt.2015.08.036_bib29","first-page":"100","article-title":"Barriers to bone marrow transplantation for sickle cell anemia","volume":"2","author":"Walters","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.036_bib30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/pbc.25439","article-title":"Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease","volume":"62","author":"Justus","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2015.08.036_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbmt.2010.08.004","article-title":"Human CD4(+)CD25(+) cells in combination with CD34(+) cells and thymoglobulin to prevent anti-hematopoietic stem cell T cell alloreactivity","volume":"17","author":"Mahmud","year":"2011","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115005972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115005972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:54:39Z","timestamp":1761058479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115005972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1083879115005972"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.08.036","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonmyeloablative Stem Cell Transplantation with Alemtuzumab\/Low-Dose Irradiation to Cure and Improve the\u00a0Quality of Life of Adults with Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}